What the tablet’s documents list
Teeth and gums do not appear in any of the three documents [1][2][3]. The relevant entries are stomach reactions with a known route to the mouth.
| Entry | Rybelsus® 7 mg / 14 mg | Placebo or status |
|---|---|---|
| Vomiting, Canadian Table 3 [3] | 6.2% / 8.4% | 3.0% |
| Gastro-oesophageal reflux disease, Canadian Table 3 [3] | 1.7% / 2.2% | 0.3% |
| Gastritis, Canadian Table 3 [3] | 1.7% / 1.7% | 0.8% |
| Altered taste (dysgeusia), EU Table 1 and US 6.2 [1][2] | Uncommon (EU); postmarketing (US) | No trial rate |
| Tooth decay, enamel erosion, gum disease [1][2][3] | Not listed | Not a recognised side effect |
What dental research says
Three reviews published in 2026 look at semaglutide and the mouth. A narrative review found dry mouth the most consistently reported oral effect, often secondary to nausea, eating less and slower stomach emptying, and listed altered taste, bad breath and more dental caries among additional findings, with limited evidence for oral thrush [4]. A review written for dental practitioners describes enamel erosion tied to vomiting, along with dry mouth, bad breath and taste changes, as indirect consequences of semaglutide’s stomach effects [5]. A third review notes that terms like “Ozempic teeth” describe patient-reported complaints, and that human data with oral-health endpoints remain scarce [6]. None of them separates tablets from injections.
Gums are an open question in the other direction. A 2026 scoping review found mechanistic and animal evidence that GLP-1 medicines might dampen periodontal inflammation, but called the human evidence indirect and insufficient to show benefit [7]. The third review reached a similar view, adding that effects on the bone around teeth remain uncertain [6].
How a stomach medicine could reach the teeth
- Acid from vomiting and reflux: both are more frequent on Rybelsus® than on placebo [3], and the dental review links vomiting to enamel erosion [5]. NIDCR explains that repeated acid exposure makes enamel lose minerals, which is how decay starts [8].
- Less saliva: dry mouth is the most consistently reported oral effect of semaglutide in the literature [4], and NIDCR notes that dry mouth can lead to sores, infections and tooth decay [9]. Our dry-mouth page covers this in detail.
- Eating patterns: smaller meals are common on the tablet, but frequent sugary drinks or snacks still feed decay-causing bacteria, according to NIDCR [8].
- Diabetes itself: high blood sugar raises the risk of gum disease, thrush and slow healing, and uncontrolled diabetes makes mouth problems more likely [9].
Two tablet details your dentist should know
First, sedation. The tablets slow stomach emptying, and the US label asks you to tell all your health care providers that you take Rybelsus® before any procedure that uses anaesthesia or deep sedation, because food may remain in the stomach and enter the lungs [1]. The EU leaflet makes the same request for surgery under anaesthesia [2]. Sedation dentistry and oral surgery fall under this.
Second, swallowing. Rybelsus® must be swallowed whole; the labels say not to split, crush or chew it, and Europe adds that it is not known whether doing so affects absorption [1][2][3]. If a sore mouth, a recent extraction or dental work makes swallowing a tablet difficult, ask your prescriber what to do rather than breaking it.
If you also use insulin or a sulfonylurea, a long dental appointment can delay a meal. The Rybelsus® label notes the higher risk of low blood sugar with these medicines [1], so it is worth telling the dental team and planning around meal times.
Other reasons teeth and gums suffer
NIDCR describes tooth decay as acid produced when mouth bacteria meet sugars and starches; older adults with receding gums can get decay on exposed roots, and early decay often has no symptoms [8]. Gum disease, dry mouth from other medicines, smoking and irregular dental care are common contributors, and NIDCR notes that smoking makes the oral problems of diabetes worse [9].
What general sources suggest
NIDCR recommends brushing twice a day with fluoride toothpaste, cleaning between the teeth with floss or another interdental cleaner, drinking fluoridated tap water or using a fluoride rinse, limiting sugary drinks, starchy snacks and frequent snacking, avoiding tobacco, and seeing a dentist for regular check-ups and cleanings [8]. Early decay, before a cavity forms, can be stopped or reversed with fluoride [8].
For people with diabetes, NIDCR suggests checking your mouth regularly for swollen or bleeding gums, dryness, soreness, white patches or a bad taste, all of which are reasons to see a dentist [9].
Rybelsus® and Ozempic® are registered trademarks of Novo Nordisk A/S. PepLabo is not affiliated with or endorsed by Novo Nordisk.
When to get help
| Sign | Who to contact | How fast | Source |
|---|---|---|---|
| After a tooth infection: fast swelling under the tongue or in the neck with trouble breathing or swallowing saliva | Emergency services (911/112) | Emergency | MedlinePlus [10] |
| Tooth pain with facial swelling and fever | A dentist the same day | Today | NIDCR [8] |
| Vomiting that does not stop, or severe stomach problems | Your prescriber the same day | Today | Rybelsus® Medication Guide [1] |
| A dental procedure with sedation or general anaesthesia coming up | Tell the dentist and your prescriber in advance | At your next appointment | Rybelsus® label [1]; EU leaflet [2] |
| Swollen or bleeding gums, white patches, soreness or a lasting bad taste | A dentist | At your next appointment | NIDCR [9] |
| Sensitivity to sweets, hot or cold, or white or brown spots on teeth | A dentist | At your next appointment | NIDCR [8] |
